Part III: As Prices Rise, So Too Does Ad Spending The average American spends $1,200 per year out-of-pocket on prescription drugs. Altogether, the 10 largest U.S.-based Big Pharma drug manufacturers pulled in a colossal $245 billion in revenue in just one year. As prescription drug prices continue to climb, causing one in four Americans to […]
Applauds Lawmakers for Advancing Market-Based Solutions to Lower Drug Prices After Years of Opposition from Big Pharma Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement praising lawmakers in the U.S. House of Representatives for passing a pair of bipartisan drug pricing bills, the CREATES Act and the Protecting Consumer […]
Part II: An Industry Booming Off of Price-Gouging The average American spends $1,200 per year out-of-pocket on prescription drugs. Altogether, the 10 largest U.S.-based Big Pharma drug manufacturers pulled in a colossal $245 billion in revenue in just one year. As prescription drug prices continue to climb, causing one in four Americans to not be […]
Commends Lawmakers of Both Parties for Working Together to Advance Key Drug Pricing Measures Through Committee Process Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement encouraging the U.S. House of Representatives to pass the bipartisan CREATES Act and Protecting Consumer Access to Generic Drugs Act of 2019 – two […]
Part I: The Math Undercuts the R&D Defense The average American spends $1,200 per year out-of-pocket on prescription drugs. Altogether, the 10 largest U.S.-based Big Pharma drug manufacturers pulled in a colossal $245 billion in revenue in just one year. As prescription drug prices continue to climb, causing one in four Americans to not be […]
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement applauding the introduction of a bill by Senators Chuck Grassley (R-IA) and Richard Durbin (D-IL) that will codify the U.S. Department of Health and Human Services’ (HHS) direct-to-consumer advertising (DTC) rule: “We applaud Senators Grassley and Durbin for building off of […]
Analysis Finds Industry Spending on Advertising, Overhead and Profits More Than Double Funding for R&D Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the findings of a study Wednesday that found the largest pharmaceutical manufacturers in the U.S. spend just 22 cents out of every dollar on research and development (R&D). The […]
Clearer Guidelines Will Increase Choice and Help Lower Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement in response to the U.S. Food and Drug Administration (FDA) announcing finalized guidance on interchangeable biologics: “This guidance marks great progress toward clearing barriers to investment in biologics that will help lower […]
Washington, D.C. – The House Energy & Commerce Subcommittee on Health held a hearing on the drug pricing supply chain Thursday. During the hearing, lawmakers from both sides of the aisle and several witnesses blasted Big Pharma for the industry’s anti-competitive tactics and price-gouging and praised bipartisan solutions to lower prices. Lawmakers also questioned the […]
Encourages House Leaders To Keep The Momentum Going Following Passage Of First Drug Pricing Bills of 116th Congress Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement following the passage of the first drug pricing bills considered by the full U.S. House of Representatives in the 116th Congress. Those bills, […]